Fred Beyerlein is a Strategic Business Advisor at NeuX Technologies. Fred has also served as President & CEO of Rubicon Genomics, and as a Member of the Advisory Board at Axios Biosciences. In addition, they were the CEO of nanoRETE, Inc., and an Advisor at the Emerging Technology Accelerator. Fred is currently a Principal at FGB Technologies, LLC.
Fred Beyerlein has an MBA in finance and economics from Fordham Gabelli School of Business, and a BS in industrial relations/economics from the University of Bridgeport.